华润进军细胞疗法领域

Insight数据库
Jun 25, 2025

6 月 25 日,华润三九官微宣布,其近日与南京艾尔普再生医学签署HiCM-188(iPSC 来源心肌细胞)在中国大陆地区的项目合作联合开发协议。来源:华润三九官微新闻稿显示,HiCM-188是全球首家在中美同时获得 IND 注册的现货型细胞创新药,也是央企深度参与的国内首个自研 iPSC 来源心肌细胞药物。HiCM-188瞄准重度心衰领域,契合了当前尚未被满足的临床需求。目前,该药物已在我国进入...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10